Automation of the In Vitro Fertilization Laboratory

Inclusion Criteria: * Informed consent signed by the patients before treatment. * Medical indication to perform assisted reproductive technology. * Body mass index between 20 and 29 kg/m2 (female participants only). * For women with indication of utilizing autologous eggs: * Anti-Müllerian Hormone (AMH) value of at least 1.5 ng/mL. * 18 - 39 years of age. * For women utilizing donor eggs (egg donor age 18-28 years): * 18 - 45 years of age. Exclusion Criteria: * Patients diagnosed with recurrent pregnancy loss. * Inaccessible ovaries for puncture. * History of total or partial fertilization failure in a previous fertility treatment. * History of repeated implantation failure defined as three previous unsuccessful embryo transfers. * Uterine factors (e.g. fibroids, uterine surgeries, Müllerian malformations) at the discretion of the medical team and based on its impact on success and/or risk to the patient or the pregnancy may compromise treatment prognosis). * Untreated hydrosalpinx * Severe endometriosis III, IV, presence of endometriomas and/or history of endometrioma resection. * Polycystic ovarian syndrome. * Patients with any of the following severe male factor infertility: * Sperm concentrations less than 5 million per mL * Progressive motility less than 5% * Others (e.g, globozoospermia and seminal infections) at the discretion of the medical team and based on its impact on success. * Surgically retrieved sperm (TESE, MESA, PESA) * Pre-existing conditions compromising reproductive (e.g., thrombophilia, chronic degenerative and autoimmune diseases, uncontrolled hormonal disorders). * Any other case of abnormalities that could compromise success rates according to the criteria of clinical personnel in charge. * Inability to adhere to the medical protocols and/or schedules for personal reasons. * Intercurrent medical disorder